Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Ultragenyx to Present at Upcoming Investor Conferences | ||
By: GlobeNewswire - 28 May 2020 | Back to overview list |
|
NOVATO, Calif., May 28, 2020 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases, today announced that it will hold virtual presentations at the following upcoming investor conferences:
The live and archived webcast of these presentations will be accessible from the company’s website at http://ir.ultragenyx.com/events.cfm. Replays of the webcasts will be available for 90 days. About Ultragenyx Pharmaceutical Inc. The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx’s strategy is predicated upon time- and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency. For more information on Ultragenyx, please visit the company's website at: www.ultragenyx.com. Contact Ultragenyx Pharmaceutical Inc. |
||
|
||
Copyright 2020 GlobeNewswire | Back to overview list |